Labiana Health, S.A.

LAB

ES0105638003

Pharmaceuticals

Market Closed - BME Other stock markets 16:35:14 07/06/2024 BST			5-day change	1st Jan Change
2.52 ^EUR	-1.56%		+12.50%	+101.60%

04-26	Labiana Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2022	Labiana Health, S.A. acquired 10.31% stake in Trichome Pharma.	CI

Labiana Health, S.A. acquired 10.31% stake in Trichome Pharma.

June 26, 2022

Labiana Health, S.A. (BME:LAB) acquired 10.31% stake in Trichome Pharma on June 27, 2022.

Labiana Health, S.A. (BME:LAB) completed the acquisition of 10.31% stake in Trichome Pharma on June 27, 2022.

Latest news about Labiana Health, S.A.

Labiana Health, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	04-25	CI
Labiana Health, S.A. acquired 10.31% stake in Trichome Pharma.	26/06/22	CI
Labiana Health, S.A. has completed an IPO in the amount of Ã‡5 million.	24/06/22	CI

Chart Labiana Health, S.A.

Duration

Period

More charts

Company Profile

Labiana Health SA is a Spain-based holding company involved in the pharmaceuticals sector. The Firm, through its subsidiaries, is engaged in the development, manufacturing and marketing of animal and human medicines. The Companyâs main activities are: Drug research and development (R&D), which includes galenic and analytical development; Drug manufacturing, which focuses on formulation development, formulation optimization, bacterial vaccine manufacturing, among others; Regulatory services, which carries out registration procedures for pharmaceutical products in world markets. The Company, through its subsidiaries, is present in Ecuador, Mexico, Serbia and Turkey.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Ratings for Labiana Health, S.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

2.52 EUR

Average target price

2.4 EUR

Spread / Average Target

-4.76%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
LABIANA HEALTH, S.A.	+101.60%	19.39M
ZOETIS INC.	-10.36%	80.73B
ELANCO ANIMAL HEALTH INCORPORATED	+22.21%	9B
BLUESTAR ADISSEO COMPANY	+24.50%	3.69B
VIRBAC	+0.97%	3.28B
VETOQUINOL SA	-0.20%	1.31B
JINYU BIO-TECHNOLOGY CO., LTD.	-26.00%	1.23B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-29.34%	1.18B
WUHAN KEQIAN BIOLOGY CO.,LTD	-23.11%	1B
SWEDENCARE AB	+1.54%	932M

Veterinary Drugs